Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia

The purpose of this study was to investigate the effect of fluvastatin on t he microcirculation of patients with hyperlipidaemia (low-density lipoprote in cholesterol > 160 mg/dL, triglycerides < 350 mg/dl) inadequately control led by diet. After a dietary run-in of 4 weeks, patients were randomised in a double-blind study to receive fluvastatin 40 mg twice daily (n = 24) or placebo (n = 24) for 12 weeks. The effect on microcirculation was assessed using capillary microscopy and laser Doppler fluxmetry at the nailfold at b aseline and at 6 and 12 weeks after initiation of therapy. Capillaroscopy s howed that fluvastatin improved microcirculation, i.e. time to peak flow. d uring postocclusive reactive hyperaemia dropped from 19.7 <plus/minus> 7.2 s at baseline to 12.3 +/- 9.5 s at week 6 (P < 0.01) and 10.6 <plus/minus> 6.5 s at week 12 (P < 0.0001). These results were confirmed using laser Dop pler fluxmetry to study microcirculation in thermoregulatory capillaries at the same site. A significant decrease in total and LDL-cholesterol was ach ieved during fluvastatin therapy. In conclusion, fluvastatin therapy improv es microcirculation in nutritive as well as thermoregulatory capillaries in hypercholesterulaemic patients within 6 weeks. <(c)> 2001 Elsevier Science Ireland Ltd. All rights reserved.